header

原著論文　学会発表　競争的資金　学位論文

原著論文

　　　

Vaccines

Oct 10, 2024

A Head-to-Head Comparative Study of the Replication-Competent Vaccinia Virus and AAV1-Based Malaria Vaccine versus RTS,S/AS01 in Murine Models

Zainal KH, Hasyim AB, Yamamoto Y, Mizuno T, Sato Y, Rasyid SH, Niikura M, Abe Y, Iyori M, Mizukami H, Shida H, Yoshida S

Front Immunol

Apr 30, 2024

A two-dose viral-vectored Plasmodium vivax multistage vaccine confers durable protection and transmission-blockade in a pre-clinical study

Yamamoto Y, Fabbri C, Okuhara D, Takagi R, Kawabata Y, Katayama T, Iyori M, Hasyim AA, Sakamoto A, Mizukami H, Shida H, Lopes S, Yoshida S

Antibodies

Sep 21, 2023

Comparison between neutralization capacity of antibodies elicited by COVID-19 natural infection and vaccination in Indonesia: A prospective cohort

Nurisyah S, Iyori M, Hasyim AA, Sakamoto A, Hashimoto H, Yamagata K, Yamauchi S, Amru K, Zainal KH, Idris I, Yoshida S, Djaharuddin I, Syafruddin D, Bukhari A, Asih PBS, Yusuf Y

Parasitol Int

Feb, 2023

Adeno-associated virus-based malaria booster vaccine following attenuated replication-competent vaccinia virus LC16m8Δ priming

Hasyim AA, Iyori M, Mizuno T, Abe YI, Yamagoshi I, Yusuf Y, Syafira I, Sakamoto A, Yamamoto Y, Mizukami H, Shida H, Yoshida S

Emerg Microbes Infect

Dec, 2022

A replication-competent smallpox vaccine LC16m8Δ-based COVID-19 vaccine

Sakamoto A, Osawa H, Hashimoto H, Mizuno T, Hasyim AA, Abe YI, Okahashi Y, Ogawa R, Iyori M, Shida H, Yoshida S

Front Immunol

Sep 29, 2022

Sterile protection and transmission blockade by a multistage anti-malarial vaccine in the pre-clinical study

Iyori M, Blagborough AM, Mizuno T, Abe YI, Nagaoka M, Hori N, Yamagoshi I, Da DF, Gregory WF, Hasyim AA, Yamamoto Y, Sakamoto A, Yoshida K, Mizukami H, Shida H, Yoshida S

Front Immunol

Jun 23, 2021

Liver-Directed AAV8 Booster Vaccine Expressing Plasmodium falciparum Antigen Following Adenovirus Vaccine Priming Elicits Sterile Protection in a Murine Model

Shahnaij M, Iyori M, Mizukami H, Kajino M, Yamagoshi I, Syafira I, Yusuf Y, Fujiwara K, Yamamoto DS, Kato H, Ohno N, Yoshida S

Gene Expr

Jun 11, 2021

Characterization of the Gene Expression Patterns in the Murine Liver Following Intramuscular Administration of Baculovirus

Iyori M, Ogawa R, Emran TB, Tanbo S, Yoshida S

Front Immunol

Oct 15, 2019

A Viral-Vectored Multi-Stage Malaria Vaccine Regimen With Protective and Transmission-Blocking Efficacies

Yusuf Y, Yoshii T, Iyori M, Mizukami H, Fukumoto S, Yamamoto DS, Emran TB, Amelia F, Islam A, Syafira I, Yoshida S

Front Immunol

Apr 5, 2019

Adeno-Associated Virus as an Effective Malaria Booster Vaccine Following Adenovirus Priming

Yusuf Y, Yoshii T, Iyori M, Yoshida K, Mizukami H, Fukumoto S, Yamamoto DS, Alam A, Emran TB, Amelia F, Islam A, Otsuka H, Takashima E, Tsuboi T, Yoshida S

Parasite Immunol

May, 2019

Down-selecting circumsporozoite protein-based malaria vaccine: A comparison of malaria sporozoite challenge model

Amelia F, Iyori M, Emran TB, Yamamoto DS, Genshi K, Otsuka H, Onoue Y, Yusuf Y, Islam A, Yoshida S

Sci Rep

Feb 28, 2019

Anopheline antiplatelet protein from mosquito saliva regulates blood feeding behavior

Islam A, Emran TB, Yamamoto DS, Iyori M, Amelia F, Yusuf Y, Yamaguchi R, Alam MS, Silveira H, Yoshida S

J Immunol

Oct 15, 2018

Baculovirus-Induced Fast-Acting Innate Immunity Kills Liver-Stage Plasmodium

Emran TB, Iyori M, Ono Y, Amelia F, Yusuf Y, Islam A, Alam A, Tamura M, Ogawa R, Matsuoka H, Yamamoto DS, Yoshida S

Sci Rep

Mar 1, 2018

Adenovirus-prime and baculovirus-boost heterologous immunization achieves sterile protection against malaria sporozoite challenge in a murine model

Yoshida K, Iyori M, Blagborough AM, Salman AM, Dulal P, Sala KA, Yamamoto DS, Khan SM, Janse CJ, Biswas S, Yoshii T, Yusuf Y, Tokoro M, Hill AVS, Yoshida S

Parasite Immunol

Dec, 2017

Protective efficacy of an IL-12-expressing baculoviral malaria vaccine

Iyori M, Blagborough AM, Sala KA, Nishiura H, Takagi K, Yoshida S

Malar J

Sep 29, 2017

DAF-shielded baculovirus-vectored vaccine enhances protection against malaria sporozoite challenge in mice

Iyori M, Yamamoto DS, Sakaguchi M, Mizutani M, Ogata S, Nishiura H, Tamura T, Matsuoka H, Yoshida S

Malar J

Apr 30, 2016

Development of a Plasmodium berghei transgenic parasite expressing the full-length Plasmodium vivax circumsporozoite VK247 protein for testing vaccine efficacy in a murine model

Mizutani M, Fukumoto S, Soubeiga AP, Soga A, Iyori M, Yoshida S

J Gene Med

Apr, 2016

Malaria sporozoite protein expression enhances baculovirus-mediated gene transfer to hepatocytes

Tamura T, Kawabata C, Matsushita S, Sakaguchi M, Yoshida S

Exp Parasitol

Dec, 2015

Reduction of conventional dendritic cells during Plasmodium infection is dependent on activation induced cell death by type I and II interferons

Tamura T, Kimura K, Yui K, Yoshida S

Vaccine

Jan 9, 2015

The Plasmodium berghei sexual stage antigen PSOP12 induces anti-malarial transmission blocking immunity both in vivo and in vitro

Sala KA, Nishiura H, Upton LM, Zakutansky SE, Delves MJ, Iyori M, Mizutani M, Sinden RE, Yoshida S, Blagborough AM

Infect Immun

Oct, 2014

Baculovirus-vectored multistage Plasmodium vivax vaccine induces both protective and transmission-blocking immunities against transgenic rodent malaria parasites

Mizutani M, Iyori M, Blagborough AM, Fukumoto S, Funatsu T, Sinden RE, Yoshida S

J Biol Chem

Jun 6, 2014

The crystal structure of the active domain of Anopheles anti-platelet protein, a powerful anti-coagulant, in complex with an antibody

Sugiyama K, Iyori M, Sawaguchi A, Akashi S, Tame JR, Park SY, Yoshida S

PLoS One

Aug 12, 2013

Protective efficacy of baculovirus dual expression system vaccine expressing Plasmodium falciparum circumsporozoite protein

Iyori M, Nakaya H, Inagaki K, Pichyangkul S, Yamamoto DS, Kawasaki M, Kwak K, Mizukoshi M, Goto Y, Matsuoka H, Matsumoto M, Yoshida S